fixed swr [RSABE / ABEL]

posted by martin  – Austria, 2013-03-29 16:07 (4330 d 23:52 ago) – Posting: # 10311
Views: 23,234

Hi Helmut !

Yep; your are totally right (should have done my homework first ;-)). what about defining the extent of scaling after interim analysis of the first stage data (CV estimated in 1st stage) within a group-sequential adaptive design?

Drawback: BUT what if the CV at interim is smaller than 0.3 ... :confused:

best regards

martin

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,665 registered users;
199 visitors (0 registered, 199 guests [including 7 identified bots]).
Forum time: 15:59 CET (Europe/Vienna)

Science is wonderfully equipped to answer the question “How?”
but it gets terribly confused when you ask the question “Why?”    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5